Company
Breye Therapeutics
- Biotech
- Headquarters:
- Hørsholm
Description
Breye Therapeutics develops orally administered ophthalmology drugs for retinal vascular diseases, focusing on diabetic retinopathy and age-related macular degeneration to reduce vision loss burden for patients and caregivers.
Related
AplagonAplagon develops first-in-class therapeutics for thromboinflammatory diseases, focusing on clinical-stage drug APAC to treat thrombotic and…
BrainEverBrainEver develops homeoprotein-based biopharmaceutical therapies to halt neurodegenerative disease progression, producing drug candidates…
Crinetics PharmaceuticalsCrinetics Pharmaceuticals develops orally delivered endocrine-targeted therapeutics, designing and advancing small-molecule drugs for…
Max-Planck-Institut für molekulare BiomedizinMax-Planck-Institut für molekulare Biomedizin conducts basic cell and vascular biology research, develops genetic technologies and…
Exact Sciences ($EXAS)Exact Sciences develops cancer screening, prevention, and therapy-guidance tests used by patients, healthcare providers, doctors,…
Age LabsAge Labs develops epigenetic biomarkers and predictive algorithms for early detection of age-related diseases and drug response, providing…
Boston Scientific Maple GroveBoston Scientific Maple Grove provides medical devices, therapy information, education, ordering, reimbursement, and support for healthcare…
Starkey Hearing TechnologiesStarkey Hearing Technologies develops and fits electronic hearing devices and related accessories, using AI-enabled and rechargeable models…
BiotalysBiotalys develops protein-based biocontrol solutions for crop protection, creating products that prevent crop loss, extend post-harvest…
Altos LabsAltos Labs researches cellular rejuvenation to restore cell health and resilience, developing therapies and computational tools aimed at…
BioArctic ABDevelops disease-modifying treatments and research programs for neurodegenerative disorders, specifically focusing on Alzheimer’s disease…
Sangamo Therapeutics ($SGMO)Sangamo Therapeutics develops genomic medicines using zinc finger, delivery, and integrase platforms for patients with severe diseases…